Julie Clarke

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Ejection Fraction

Palliative Care

Papillary Thyroid

Patient Reported

Top Venues

JMIR formative research

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Emma Dunlop, Aimee Ferguson, Tanja Mueller, Kelly Baillie, Jennifer Laskey, Julie Clarke, Amanj Baker Kurdi, Ann Wales, Thomas Connolly, Marion Bennie
Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study. JMIR formative research 7 (2023)
Emma Dunlop, Aimee Ferguson, Tanja Mueller, Kelly Baillie, Jennifer Laskey, Julie Clarke, Amanj Baker Kurdi, Ann Wales, Thomas Connolly, Marion Bennie
Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study. JMIR formative research 7 (2023)
Emma Dunlop, Aimee Ferguson, Tanja Mueller, Kelly Baillie, Jennifer Laskey, Julie Clarke, Amanj Baker Kurdi, Ann Wales, Thomas Connolly, Marion Bennie
Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study. JMIR formative research 7 (2023)
Emma Dunlop, Aimee Ferguson, Tanja Mueller, Kelly Baillie, Jennifer Laskey, Julie Clarke, Amanj Baker Kurdi, Ann Wales, Thomas Connolly, Marion Bennie
Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study. JMIR formative research 7 (2023)
Julie Clarke, Marion Bennie, Amanj Baker Kurdi, Jiafeng Pan, Tanja Mueller, Christine Crearie, Kelly Baillie, Jennifer Laskey, Ashita Waterston
Real-world effectiveness of systemic anticancer therapy for advanced melanoma in the west of Scotland from 2010 to 2018. Future oncology (London, England) (2023)